The continuing problem of human African trypanosomiasis (sleeping sickness).
about
Early invasion of brain parenchyma by African trypanosomesNuclear DBF-2-related kinases are essential regulators of cytokinesis in bloodstream stage Trypanosoma bruceiThe ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!Drug repurposing and human parasitic protozoan diseasesMelarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasisOne Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual ScreeningThe crystal structure of Leishmania major N5,N10-methylenetetrahydrofolate dehydrogenase/cyclohydrolase and assessment of a potential drug targetCrystal structures of Trypanosoma brucei oligopeptidase B broaden the paradigm of catalytic regulation in prolyl oligopeptidase family enzymesDyes, trypanosomiasis and DNA: a historical and critical reviewTrypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leadsAquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprolAdult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa.Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solution.Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouseA combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsImproving the cost-effectiveness of artificial visual baits for controlling the tsetse fly Glossina fuscipes fuscipesMurine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropismAssessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.Identification of stage biomarkers for human African trypanosomiasis.The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness.Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.Actigraphy in human African trypanosomiasis as a tool for objective clinical evaluation and monitoring: a pilot studyControl of neglected tropical diseases needs a long-term commitmentManadoperoxides, a new class of potent antitrypanosomal agents of marine origin.Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentComparative gene expression of Wigglesworthia inhabiting non-infected and Trypanosoma brucei gambiense-infected Glossina palpalis gambiensis fliesMagnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis.Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.Parasitic infections in HIV infected individuals: diagnostic & therapeutic challengesFalse positivity of non-targeted infections in malaria rapid diagnostic tests: the case of human african trypanosomiasis.Trypanocidal furamidine analogues: influence of pyridine nitrogens on trypanocidal activity, transport kinetics, and resistance patterns.Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisAn arginine-glycine-rich RNA binding protein impacts the abundance of specific mRNAs in the mitochondria of Trypanosoma brucei.Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.Vertical transmission of Bartonella schoenbuchensis in Lipoptena cervi.Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessInterleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.Quinol derivatives as potential trypanocidal agentsAn agent-based model to simulate tsetse fly distribution and control techniques: a case study in Nguruman, Kenya.Multiorgan dysfunction caused by travel-associated African trypanosomiasis.
P2860
Q21089852-164A40EC-DAB2-4641-9F90-4ACC2924CCDFQ24627940-9C738857-52DE-4DD8-A324-F2A160FE64D8Q26781588-B7FC25A1-A679-4A73-80BC-FF584E9A679DQ26999453-9026DB88-4142-4BFD-9102-6A72C5FD5178Q27306003-A2E86305-523C-49F6-8266-4FA0A102AADDQ27655956-32F66BCD-46E9-40C1-B042-A9CBBF510696Q27675760-A039DE44-620D-4F64-9D1C-0C45C96F333EQ27680672-B782CBB9-93F2-4B0E-92CB-79B5A80E4510Q28298491-C33F1188-3E8D-4438-8B4B-AC16F72B323FQ28477646-BC152C20-28FE-412B-A9DC-C3B9E2EDFFCAQ28534313-6EAA3CFB-1912-4993-8595-F839B47D436AQ30877850-C8DDB1D7-1344-4A15-96D7-3A3CA970CBD2Q30938677-0B5049FC-4BD7-47F2-8A0B-B72B1A5657E6Q33458697-8C5EA6D3-4217-4951-BC87-66FC9A0CFA1DQ33474338-116C262B-D0C3-44B5-8D63-2C7610E3ED4BQ33479109-6DF563FD-12FF-4B11-B03D-A0D1CA503E21Q33498933-4BDD3C87-8561-4B34-8D09-273C685E64F9Q33543529-7A5BF18F-4E1E-4663-9E47-C3EC0FE12E72Q33880764-72569C1B-5558-4DB4-956A-D03C70A403A8Q33893778-10CFCB07-DAD1-4725-A6B6-20C0E238A125Q34150973-5DF8E3B0-BAC3-4B31-98A5-DAD83F91BC97Q34163935-819EF385-9E82-49D1-994E-8609FB2FA99BQ34331536-5AC96FC6-2FA7-4045-9265-88DD7D4C263DQ34363517-5ACF167F-9770-4990-B0C2-F858BA7930E3Q34466454-0345322E-71DE-4D21-9DC0-CBB960C86133Q34521842-81627977-9440-4712-B185-8E405B84B9E1Q34531379-BEF11043-E955-4556-8C9B-27B312C32435Q34613654-71846C69-789F-436A-85E2-90B753A6BD59Q34635675-5A8B82E0-7594-4223-857F-5D689FA83095Q34702477-C19AA584-0A6E-493A-B0F4-3ABCC963D17CQ34933034-152975C0-AF75-4EC8-AFC1-06295DCF7967Q35006575-D7E95EDA-1022-4B4D-86DA-94166FAFEF43Q35031707-F9C3271A-CD99-4F73-91DA-33DE6DEB9696Q35105858-4828FA99-A472-4DCC-847E-E19CB175F916Q35218206-8F466B4F-DA3F-49CA-AC7F-0F568619A382Q35598430-B00B842F-457B-4BC0-9FC9-F26F8E3942CAQ35668603-CFAAD794-9B49-4C90-847A-9CE21BB51A93Q35761636-03999AF4-A202-4825-BA76-B7CB1EB4FEB1Q35984918-CD819384-2627-44AB-9A9F-2CED9F3ED373Q36002552-4B40B97D-68B6-4D30-AE98-1AE373B2838C
P2860
The continuing problem of human African trypanosomiasis (sleeping sickness).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The continuing problem of human African trypanosomiasis (sleeping sickness).
@en
The continuing problem of human African trypanosomiasis
@nl
type
label
The continuing problem of human African trypanosomiasis (sleeping sickness).
@en
The continuing problem of human African trypanosomiasis
@nl
prefLabel
The continuing problem of human African trypanosomiasis (sleeping sickness).
@en
The continuing problem of human African trypanosomiasis
@nl
P921
P356
P1433
P1476
The continuing problem of human African trypanosomiasis (sleeping sickness).
@en
P2093
Peter G E Kennedy
P2860
P304
P356
10.1002/ANA.21429
P577
2008-08-01T00:00:00Z